ClinicalTrials.Veeva

Menu

The Effects of Soy Dietary Fiber in Adults With Diarrhea Predominant Irritable Bowel Syndrome

Seoul National University logo

Seoul National University

Status

Unknown

Conditions

Diarrhea Predominant Irritable Bowel Syndrome

Treatments

Dietary Supplement: Rice powder
Dietary Supplement: Soy Dietary Fiber

Study type

Interventional

Funder types

Other

Identifiers

NCT01373034
CHUNG_SOY

Details and patient eligibility

About

The investigators will evaluate the efficacy of soy dietary fiber in adults with diarrhea predominant irritable bowel syndrome.

Enrollment

36 estimated patients

Sex

All

Ages

19 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • willing to consent/undergo necessary procedures
  • between the age of 19 and 75 years
  • diarrhea predominant irritable bowel syndrome (satisfied with Rome II criteria)

Exclusion criteria

  • uncontrolled hypertension (Blood pressure > 170/100 mmHg)
  • uncontrolled diabetes mellitus (FBS > 180 mg/dL)
  • malignancy, cerebrovascular disease, cardiovascular disease
  • history of abdominal surgery except appendectomy and hernia repair
  • inflammatory bowel disease
  • clinically or laboratory-confirmed gastroenteritis
  • the use of motility drug or dietary fiber supplement in 2 weeks
  • allergy to soy fiber
  • serum Cr > 2 x Upper normal limit
  • AST or ALT > 2 x Upper normal limit
  • Pregnancy, Lactating woman

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

36 participants in 2 patient groups, including a placebo group

Soy Dietary Fiber
Experimental group
Treatment:
Dietary Supplement: Soy Dietary Fiber
Rice powder
Placebo Comparator group
Treatment:
Dietary Supplement: Rice powder

Trial contacts and locations

1

Loading...

Central trial contact

Kyoung Sup Hong, M.D.; Joo Sung Kim, M.D., PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems